PrecisePK Pioneers Model-Informed Precision Dosing and Pharmacokinetics Advancements in Argentina with Maza University
Retrieved on:
Mittwoch, Dezember 6, 2023
Clinical pharmacy, Health, Clinical, Acquisition, SAN, Evidence-based practice, Plasma, Risk, Student, Patient, Pharmacology, Medicine, Anticonvulsant, Faculty, Pharmacokinetics, Blood, Health system, Software, Partnership, Huế Central Hospital, Intensive care medicine, Neurology, Education, Knowledge, Central Hospital, Juan Agustín Maza University, Pharmaceutical industry, Nursing, Biochemistry, Pharmacy
Through a strategic collaboration with the reputable Faculty of Pharmacy and Biochemistry, Maza University became the inaugural institution in Argentina to acquire pivotal pharmacokinetics software.
Key Points:
- Through a strategic collaboration with the reputable Faculty of Pharmacy and Biochemistry, Maza University became the inaugural institution in Argentina to acquire pivotal pharmacokinetics software.
- Maza University leverages PrecisePK for Bayesian personalized drug dosing in Argentina, advancing clinical education.
- "The acquisition of this software is of great relevance for the academic and scientific community since it makes Maza University the first university in Argentina to acquire a Bayesian Model-Informed Precision Dosing software for the training of its students in pharmacokinetics.
- This strategic alignment between PrecisePK and Maza University symbolizes an unprecedented fusion of academic prowess and real-world application.